Finance

Lists
Q2 2026 earnings • released • EPS beat +14.63% • Revenue beat +5.38%
See results
APYX:NASDAQ
Apyx Medical Inc
$4.05
-2.64%
(-0.11) 1D
Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APYX...
Open
$4.16
High
$4.25
Low
$3.40
Mkt. cap
169.74M
Avg. vol.
81.33K
Volume
299.18K
52-wk high
$5.08
52-wk low
$1.70
EPS
-$0.22
Beta
1.39
Shares outstanding
41.91M
No. of employees
205
Open
$4.16
High
$4.25
Low
$3.40
Mkt. cap
169.74M
Avg. vol.
81.33K
Volume
299.18K
52-wk high
$5.08
52-wk low
$1.70
EPS
-$0.22
Beta
1.39
Shares outstanding
41.91M
No. of employees
205
News stories
From sources across the web
About Apyx Medical Inc
CEO-
Employees205
Founded1982
HeadquartersClearwater, Florida, United States
SectorMedical device
Websiteapyxmedical.com
Analyst ratings
Based on 2 analysts giving stock ratings to APYX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for APYX in the last 3 months.
Highest
Current $4.05
$7.00 (+72.84%)
Average
$6.50 (+60.49%)
Lowest
$6.00 (+48.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sam Eiber
BTIG
Buy
Reiterated
$6.00
+48.1%
08/07/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$7.00
+72.8%
08/07/2026
Matt Hewitt
Craig-Hallum
Buy
Reiterated
$6.00
+48.1%
05/08/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$6.00
+48.1%
04/14/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.07 / -$0.08
+14.63%beat
Revenue / Est. (USD)
13.88M / 13.18M
+5.38%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.88M
19.16M
12.49M
13.88M
Cost of goods sold
4.58M
7.16M
4.56M
5.01M
Cost of revenue
4.58M
7.16M
4.56M
5.01M
Research and development expenses
801.00K
944.00K
765.00K
793.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.33M
11.04M
8.07M
9.88M
Operating expense
9.13M
11.99M
8.84M
10.68M
Total operating expenses
13.71M
19.15M
13.40M
15.69M
Operating income
-832.00K
11.00K
-911.00K
-1.81M
Other non operating income
76.00K
16.00K
36.00K
2.00K
EBT including unusual items
-1.88M
-1.15M
-2.00M
-2.95M
EBT excluding unusual items
-1.88M
-1.15M
-2.00M
-2.95M
Income tax expense
78.00K
94.00K
143.00K
124.00K
Effective tax rate
-4.16%
-8.20%
-7.15%
-4.21%
Other operating expenses
-
-
-
-
Net income
-1.98M
-1.30M
-2.11M
-3.24M
Net profit margin
-15.41%
-6.78%
-16.88%
-23.36%
Earnings per share
-0.05
-0.03
-0.05
-0.07
Interest and investment income
292.00K
234.00K
244.00K
250.00K
Interest expense
-1.41M
-1.41M
-1.37M
-1.39M
Net interest expenses
-1.12M
-1.17M
-1.12M
-1.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
-668.00K
232.00K
-709.00K
-1.60M
Gain or loss from assets sale
19.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps